Team2023-08-28T19:30:49+00:00“Mini” U.S. Innovation & Competition Act Senate Passage This MonthTeam2023-08-28T19:30:49+00:0007/20/2022|
Team2023-08-28T19:33:18+00:00Momentum Builds for Drug Reform PassageTeam2023-08-28T19:33:18+00:0007/19/2022|
Team2023-08-28T20:51:06+00:00Rx Negotiation in BBB Spurs ‘Clean’ FDA User Fee BillTeam2023-08-28T20:51:06+00:0007/15/2022|
capitolstreet2023-08-16T16:31:10+00:00PFS Odds & Ends: Primary Care Bump, ACO Tweaks Could Bleed to MA Somedaycapitolstreet2023-08-16T16:31:10+00:0007/08/2022|
Team2023-08-28T19:36:48+00:00Drug Deal Comes Together: Pass by Aug RecessTeam2023-08-28T19:36:48+00:0006/30/2022|
capitolstreet2023-08-16T16:30:21+00:00SCOTUS Rules Against DaVitacapitolstreet2023-08-16T16:30:21+00:0006/21/2022|
Team2023-08-28T19:43:48+00:00FTC Workshop: Update Pharma Merger GuidelinesTeam2023-08-28T19:43:48+00:0006/14/2022|
Team2023-08-28T19:46:34+00:00FDA User Fees Pass House, Senate Is NextTeam2023-08-28T19:46:34+00:0006/10/2022|
Team2023-08-28T19:48:37+00:00FTC Pharma Bills May Be In Mix With BBBTeam2023-08-28T19:48:37+00:0006/08/2022|